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The infection of foetal thymus with coxsackievi-
rus B4 (CV-B4) E2 has been studied ex vivo by
using CD-1 mice on foetal day 14, as a ready
source of organs for experimentation to inves-
tigate the hypothesis of the role of thymic viral
infections in the pathogenesis of type 1 diabetes.
The replication of CV-B4 E2 in murine foetal
thymus organ cultures has been demonstrated
by evaluating the levels of positive- and negative-
stranded viral RNA in cells by using a real-time
quantitative RT-PCR method and by determining
titres of infectious viral particles in culture super-
natants for 7 days post-infection (p.i.). Staining of
tissue sections with an anti-cytokeratin antibody
and haematoxylin–eosin showed that CV-B4
infection had no visible effect on cell survival
and organ integrity. Cell counts in mock- and
virus-infected foetal thymus organ cultures
increased from day 1 through day 7, and live cell
numbers were comparable in both conditions
as shown by Trypan blue exclusion test and
7-amino-actinomycin D staining of thymocytes.
Compared with controls on day 7 p.i., cytofluoro-
metric analyses on cells from CV-B4 E2-infected
foetal thymus organ cultures displayed a marked
increase in the percentage of the most immature
CD3CD4CD8 thymocytes, and a decrease in
the percentage of immature CD3CD4þCD8þ
cells, together with an increase in the percentage
of mature CD3þCD4þ and CD3þCD8þ cells. These
data show that CV-B4 E2 disturbs T-cell matura-
tion and differentiation processes in infected
murine foetal thymus organ cultures and provide
evidence of a suitable system to investigate the
effect of viruses in T-cell differentiation. J. Med.
Virol. 80:659–666, 2008.  2008 Wiley-Liss, Inc.
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INTRODUCTION
Type 1 diabetes is a multifactorial disease that obeys
to a genetic predisposition, determined by a balance
between susceptibility and resistance alleles, and is
triggered by environmental factors such as viruses.
Seroepidemiological data implicated largely enterovi-
ruses, especially type B coxsackieviruses (CV-B), in type 1
diabetes development [Helfand et al., 1995; Hyo¨ty et al.,
1995] and several studies observed the presence of
nucleotide sequences of those viruses in the blood of
patients with that disease (reviewed by Hyo¨ty et al.,
2002). Among CV-B or enterovirus genus, CV-B4 is one
of the serotypes most frequently associated with the
disease in prediabetic and diabetic patients [Gamble
et al., 1973; Chehadeh et al., 2000b]. The diabetogenic
strain CV-B4 E2 was isolated from the pancreas of a
child who died from diabetic ketoacidosis and was able to
induce hyperglycaemia in some susceptible mouse
strains [Yoon et al., 1979].
Type 1 diabetes is an autoimmune disease which
results from the loss of or defect in immune tolerance
establishment [Sinha et al., 1990]. Self-tolerance is
initiated in the thymus during T-cell ontogeny [Geenen
and Kroemer, 1993; Martens et al., 1996; Geenen et al.,
2001], a multi-step process which starts as soon as foetal
life. The thymus fulfils this function by two comple-
mentary mechanisms: the deletion of T cells directed
against self-antigens presented in the thymic cellular
environment (thymic epithelial cells, macrophages and
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dendritic cells) by major histocompatiblity complex
(MHC) proteins, and the generation of self-antigen
specific regulatory T cells (TREG).
It has been reported that a viral infection of thymus
can facilitate immune tolerance to antigens of that
infectious agent, which can result in viral persistence
[Korostoff et al., 1990; King et al., 1992]. Vertical
transmission of CV-B associated with foetal thymus
infection has been reported [Iwasaki et al., 1985;
Lozovskaia et al., 1997]. In addition, it has been shown
that enterovirus infections in utero may induce b-cell
autoimmunity [Otonkoski et al., 2000], and that
CV-B4 infection during pregnancy was a risk factor for
childhood-onset type 1 diabetes [Dahlquist et al., 1995;
Hyo¨ty et al., 1995].
It has been suggested that foetal infection with CV-B
may initiate autoimmunity or cause persistent infec-
tion that may lead to a progressive b-cell destruction
and thus could play a role in the pathogenesis of type 1
diabetes [Dahlquist et al., 1995]. Furthermore, mas-
sive thymic depletion and/or CV-B4 E2-induced abnor-
mal lymphocyte maturation have been linked to
autoimmunity with possible insulitis and hyperglycae-
mia in mice models [Chatterjee et al., 1992; Shih et al.,
2004].
These data suggest a role for CV-B4 infection of the
thymus in the emergence of type 1 diabetes in individ-
uals predisposed genetically. Through thymus infection,
CV-B4 may severely impair the physiologic function of
that organ. In this perspective, it has been demonstrated
previously that CV-B4 can persistently infect primary
cultures of human thymic epithelial cells and modulate
the profile of LIF, IL-6 and GM-CSF secretion by these
cells [Brilot et al., 2002]. It has also been observed that
CV-B4 infection of cultures of human foetal thymus
dissected into small pieces resulted in a dramatic
depletion of immature CD4þCD8þ thymocytes with
an increased expression of MHC I that is one of the
three-molecular complex TCR/MHC/self-antigen actors
responsible for negative selection of self-reactive T cells
in the thymus [Brilot et al., 2004].
Mice constitute a universal model for studying several
aspects related to type 1 diabetes that are difficult to
investigate in humans. It has been observed that CV-B4
E2 can infect the thymus in vivo in a mouse model of
virus-induced type 1 diabetes [Chatterjee et al., 1992],
which resulted in a significant increase in CD4CD8
thymic T cells, suggesting that CV-B4 E2 can induce an
abnormal T lymphocyte maturation that may be
involved in the development of type 1 diabetes.
To investigate further the hypothesis of the role of
thymic viral infections in the pathogenesis of type 1
diabetes, it is essential to have a system which is easy to
handle and providing ready access to a source of foetal
thymus for experimentation. Therefore we developed a
model of murine foetal thymus organ cultures infected
with CV-B4 E2, in order to study the interaction of CV-
B4 E2 with that organ and to assess whether such an
infection can result in a disturbance of the pattern of
thymocyte populations ex vivo.
MATERIALS AND METHODS
Animals and Tissue Collection
Adult CD-1 outbred mice were obtained from the
Centre d’Elevage Janvier (Le Genest St Isle, France) and
bred in the animal facility of the Institute of Pathology at
the University of Liege. Mice were mated overnight
(16 hr) and foetuses were removed at day 14 of gestation
(plug date¼day 0). The experimental procedures were
carried out in accordance with the Ethical Committee on
Animal Experimentation of the University of Liege.
Virus
The diabetogenic strain CV-B4 E2 (provided by J.W.
Yoon, Julia McFurlane Diabetes Research Center,
Calgary, Alberta, Canada) was generated as described
previously [Brilot et al., 2002]. Briefly, CV-B4 E2 was
grown in Vero cells (American Type Culture Collection,
Manassas, VA) in Eagle’s Minimum Essential Medium
(Cambex, Verviers, Belgium) supplemented with 10%
foetal calf serum (FCS) (a generous gift from Dr. M. De
Smedt, University of Gent, Belgium). Supernatants
were collected 3 days after inoculation, clarified at
1,200g for 10 min, divided into aliquots and stored at
808C. Virus titres in stocks were determined on Vero
cells by limiting dilutions assay for 50% tissue culture
infectious doses (TCID50) by the method of Reed and
Muench [1938].
Foetal Thymus Organ Cultures
Foetal thymus organ cultures were performed as
described previously [Plum et al., 1995; Kecha et al.,
2000]. Briefly, single foetal thymus lobes from CD-1
mice on foetal day 14 were directly transferred into
CV-B4 E2 stocks at a 104 TCID50 per lobe for 4 hr at 378C
in a 5% CO2 incubator. Lobes were then transferred onto
sterile filters of 0.8 mm pore size (Nucleopore Costar,
Cambridge, MA) placed on Gelfoam (Pharmacia-Upjohn
Kalamazoo, MI) rafts in 700 ml of Iscove’s modified
Dulbecco’s medium (Cambex) supplemented with
L-glutamine(2mM),HEPES(25mM),non essential amino
acids (1%), sodium pyruvate (1%), streptomycin (100 mg/
ml), penicillin (100 UI/ml) (all reagents purchased from
Cambex), and FCS (10%), in 24-well culture plates.
Mock-infected foetal thymus organ cultures were incu-
bated 4 hr in non-infected Vero cells culture supernatant
then treated in the same way and served as a negative
control. Foetal thymus organ cultures were incubated
7 days, and the medium was collected and changed
on days 0, 3 and 7 post-infection (p.i.). At the end of the
culture, individual thymus lobes were dispersed and cell
suspensions were prepared by crushing. Living cells
were estimated by Trypan blue dye exclusion test. Cells
were also washed and stained for CD3, CD4, CD8, and
7-amino-actinomycin D (7-AAD, BD Pharmingen,
San Diego, CA) and then examined by fluorescence-
activated cell sorting (FACS).
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Quantitative RT-PCR for CV-B4 E2
CV-B4 E2 positive- and negative-stranded RNA in
foetal thymus organ cultures were quantified at days 0, 3
and 7 p.i. by two-step quantitative RT-PCR by using the
TaqMan fluorogenic detection system with AmpliTaq
Gold reagents (Applied Biosystems, Foster City, CA) as
previously described [Brilot et al., 2004]. Briefly, total
RNA was extracted from thymic lobes with
RNeasy minikit (Qiagen Valencia, CA), resuspended in
water, and quantified by using RiboGreen quantifica-
tion kit (Invitrogen Carlsbad, CA) according to the
manufacturer’s instructions. Total RNA was measured
by a quantitative RT-PCR for rRNA expression with the
TaqMan rRNA control reagent (Applied Biosystems).
Positive- and negative-strand-CV-B4 E2 specific RT was
carried out with 12 ng of rRNA and either the reverse or
forward primer at 488C for 30 min. PCR was performed
under universal cycle conditions (10 min at 958C,
40 cycles of 15 sec at 958C and 1 min at 608C) on an
ABI Prism 7700 sequence detector (Applied Bio-
systems). The following primers, used to detect CV-B4
E2, were located within the enterovirus 50-nontranslat-
ed region, which is highly conserved among enterovirus
serotypes: CV-B4 E2 forward (50-GTAGTCCTCCGGC-
CC CT-30) and CV-B4 E2 reverse (50-AATTGTCACCA-
TAAGCAGCCA-30). The sequence of the probe was
50-VIC-ATGCGGCTAATCCTAACTGCGGAG-TAMRA-
30 (Applied Biosystems). The RNA copy number in each
sample was determined as described elsewhere by a
standard curve generated from increasing copy number
of a synthetic transcript corresponding to 435 nt of the
CV-B4 E2 genome [Brilot et al., 2004]. Briefly, 435 nt
within the enterovirus 50-nontranslated region were
reverse transcribed and amplified with primers
described previously [Leparc et al., 1994]. The PCR
product was cloned in pCR2.1-TOPO (Invitrogen), se-
quenced, and subcloned to two different T7 promoter-
containing pBluecript II KS(þ) vectors to obtain a
positive and negative strand after in vitro transcription.
Sense and anti-sense synthetic RNA generated with a
T7 Megascript RNA transcription kit (Ambion) were
measured by spectrophotometry and diluted to obtain a
standard curve. The absence of contaminating DNA
from plasmid in standards and genomic DNA in samples
was checked by RT-PCR without the reverse tran-
scriptase enzyme. Primers and probes were designed
with the PrimerExpress software, and the data were
analysed with Sequence Detection System SDS 1.9.1
(both from Perkin-Elmer, Boston, MA).
Quantitation of Infectious Virus in Foetal
Thymus Organ Cultures Supernatants
The ability of murine foetal thymus organ cultures to
yield infectious viral particles was measured by Reed–
Muench’s method [Reed and Muench, 1938] performed
in Vero cells. Viral titres were determined in culture
supernatants collected on days 0, 3 and 7 p.i. and
expressed as TCID50/ml.
Immunohistochemistry and Histology
On day 7 p.i., single thymus lobes were embedded in
Tissue-TEK1 (Sakura) and frozen at 808C. Five mm
tissue sections were fixed for 10 min in 4% paraformal-
dehyde at 48C and washed in buffer (Tris–HCl 0.5 M pH
7.6; NaCl 9%; Tween 20 2%, NaN3 2% in H2O). Slides
were incubated in a humidified chamber with rabbit
polyclonal anti-mouse cytokeratin (CK) (A575, Dako,
Glostrup, Denmark) for 2 hr at room temperature. The
slides were washed and stained with secondary antibody
FITC-conjugated goat anti-rabbit IgG (Jackson Immu-
noResearch Laboratories Inc., West Grove, PA) for 1 hr
at room temperature, washed again, and mounted with
glycerol-gelatin medium. Slides were examined with a
fluorescence microscope (Olympus, France).
Alternatively, 5 mm tissue sections were also stained
by using routine haematoxylin–eosin staining. Sections
were incubated with 0.25% haematoxylin reagent and
0.5% eosin (Merck Biosciences, Leuven, Belgium), then
dehydrated with graded isopropanol, treated with
xylene and mounted with Entellan medium (Merck
Biosciences).
FACS Staining and Analyses
After 7 days of culture, dispersed thymocytes from
foetal thymus organ cultures were washed, pelleted,
resuspended in 50 ml of monoclonal antibodies and
incubated for 30 min at 48C. After incubation, cells were
rinsed, pelleted, and resuspended in 200ml of phosphate-
buffered saline–2% FCS for FACS analysis. Two- or
three-colour FACS staining was performed with the
indicated combinations of the following antibodies: anti-
CD3-peridinin-chlorophyll protein (PerCp), anti-CD4-
phycoerythrin (PE), and anti-CD8-fluorescein isothio-
cyanate (FITC) (all from BD Pharmingen). Viability was
assessed with 7-AAD (BD Pharmingen). Samples were
examined immediately after staining on a FACSCalibur
by using CELLQuest software (Becton Dickinson).
Statistical Analyses
Statistical analyses were performed using Mann–
Whitney’s nonparametric test. The data are expressed
as means standard deviations (SD).
RESULTS
Murine Foetal Thymus Organ Cultures Undergo
Cellular Growth and Differentiation In Vitro
In order to assess the growth of thymic lobes in
culture, the number of viable cells was evaluated on days
0 and 7. Foetal thymic lobes were isolated from CD-1
mice foetus on the 14th day of gestation and contained a
mean of 16,006 8,260 cells per lobe (n¼37). After
7 days of culture, the number of cells per lobe was
multiplied by 9, with a mean of 141,667 79,400 cells
per lobe (n¼9) in mock-infected foetal thymus organ
cultures for example (Table I), showing proliferation of
thymocytes within the lobes during culture. The cell
J. Med. Virol. DOI 10.1002/jmv
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viability began to decline after the first week of culture,
which limited the culture period to 7 days in our
investigation. A double staining of thymocytes for CD4
and CD8 was then performed and thymocyte subpopu-
lations were analysed by flow cytometry. Results were
expressed as percentages of living cells. On day 0, the
majority of thymocytes were CD4CD8 (98%) with
about 1% of CD4þ. After 7 days of culture in control
cultures, thymocytes differentiated into 4 different
subsets: 25% of thymocytes were CD4CD8, 52% were
CD4þCD8þ, 15% were CD4þ and 8% were CD8þ,
confirming successful thymocyte differentiation in
foetal thymus organ cultures.
CV-B4 E2 Infects Murine Foetal Thymus
Organ Cultures
Virus replication in thymic lobes. Amplification
and quantification of CV-B4 E2 positive- and negative-
stranded RNA by RT-PCR made it possible to determine
whether the virus infected the thymic lobes and whether
it was replicating. Table II shows that the number of
copies of positive-stranded CV-B4 E2 RNA markedly
increased between day 0 and day 3, reached a peak
on day 3, and then decreased between day 3 and day 7
p.i. The same pattern of expression was observed for CV-
B4 E2 negative-stranded RNA. No CV-B4 E2 positive- or
negative-stranded RNA was detected in mock-infected
samples (negative control, data not shown).
Virus titration in foetal thymus organ cultures
supernatants. Virus titres in supernatants of CV4
E2-infected foetal thymus organ cultures were then
assessed. CV-B4 E2 infection led to increased virus
titres from day 0 to day 3 (Table III), followed by a
dramatic decrease until day 7 p.i., suggesting that a
release of virus particles occurred during the first days of
the culture. Titration of virus in supernatants of mock-
infected foetal thymus organ cultures was also per-
formed and no viral particle was detected in these
samples (data not shown).
Organ integrity after CV-B4 E2 infection. To
investigate whether CV-B4 E2 could impair thymus
integrity, histological staining of thymic lobes sections
was performed. Compared to mock-infected foetal thy-
mus organ cultures, CV-B4 E2 infection did not damage
the thymus architecture and did not induce obvious cell
lysis (Fig. 1). Neither necrosis nor histopathological
damage could be observed at higher magnification
(Fig. 1). The detection of cellular cytokeratins has
previously been shown to identify the network of thymic
epithelial cells within the thymus [Brilot et al., 2002], and
thus can be used as a marker of tissue integrity. No
difference in the cytokeratin staining could be observed
between mock- and CV-B4 E2-infected thymic lobes
(Fig. 1d,h), suggesting that integrity of the thymus
network was preserved after CV-B4 E2 infection. Results
were similar in both cortex and medulla.
CV-B4 E2 Infection Disturbs T-cell
Differentiation In Vitro
First, the cell viability was assessed in foetal thymus
organ cultures to determine whether the cultures were
affected by CV-B4 E2 infection. There was no significant
difference in total numbers and percentages of viable
cells between mock- and CV-B4 E2-infected foetal
thymus organ cultures, using Trypan blue dye exclusion
test followed by cell counting or 7-AAD staining followed
by flow analysis (Table I).
Then, the effect of CV-B4 E2 infection was studied on
thymocyte differentiation in murine foetal thymus
organ cultures. Thymocytes are known to evolve from
the most immature stage CD3CD4CD8 (CD3
double negative or CD3 DN) to CD3 CD4þCD8þ
(double positive or CD3 DP) before becoming fully
mature single positive cells, either CD3þCD4þ or
CD3þCD8þ. Cells were gated into two main subpopula-
tions: the immature CD3 cells or the mature CD3þ
thymocytes. Results were expressed as percentages of
living cells (Fig. 2).
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TABLE I. Cell Viability in Mock- and CV-B4 E2-Infected Foetal Thymus Organ Cultures at
7 Days Post-Infection
Number of living cells by Trypan
Blue dye exclusion test (n¼ 9)
Percentage of living cells by
7-AAD staining (%) (n¼ 6)
Mock 141,667 79,402 87.37 9.62
CV-B4 E2 128,056 53,906 86.61 6.36
Results are expressed as meanSD.
TABLE II. Intracellular Positive- and Negative-Stranded RNA Detection in Murine Foetal
Thymus Organ Cultures Infected with CV-B4 E2 at Different Times Post-Infection
Number of copies of CV-B4 E2 RNAa (mean valueSD, n¼ 2)
Day 0 p.i. Day 3 p.i. Day 7 p.i.
Positive strands 2,210.44 933 31,825.9 20,044 2,564.7 3,623
Negative strands 3,100.3 1,780 64,501.2 17,949 2,975.2 4,202
aThe results were obtained by using quantitative real-time PCR and were expressed as copies/12 ng of
ribosomal RNA.
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Within immature thymocytes (CD3), CV-B4 E2
infection induced a significant decrease in the CD3DP
DP subset compared with mock-infected cultures
(2710.5% vs. 586.5%, n¼4, P< 0.05), and a signifi-
cant increase in CD3DN thymocytes (52.5 13.5% vs.
216.5%, n¼4, P<0.05).
As regards mature thymocytes (CD3þ), CV-B4 E2
infection induced a significant increase in CD3þCD4þ
and CD3þCD8þ populations compared with mock-
infected cultures (12 4% vs. 6.51.5%, n¼4,
P< 0.05, and 10 3.5% vs. 42%, n¼ 4, P< 0.05,
respectively).
DISCUSSION
Access to human foetal thymus being very limited
(forbidden for ethical reasons in the European Union), it
is important to develop alternative models as a tissue
source for experimentation. In the current work,
advantage was taken of thymocyte differentiation ex
vivo, in murine foetal thymus organ cultures, to study
the infection of that system with CV-B4 E2, and its
consequences on thymocyte differentiation.
Foetal thymus organ culture is a method that
maintains the three-dimensional architecture of thy-
mus and its cellular composition and allows in vitro
growth and differentiation of thymic lobes [Bonyhadi
et al., 1995; Kecha et al., 2000; Brilot et al., 2004]. It has
been reported that, like human foetal thymus organ
cultures, murine foetal thymus organ cultures closely
mimic physiological conditions and therefore provide a
very appropriate in vitro model and a more rapid means
for the study and manipulation of T-cell development
compared with alternative in vivo approaches [Plum
et al., 1995; Owens et al., 2005]. However, foetal thymus
organ cultures have not been used extensively to
investigate the consequences of a virus infection, and
most studies were performed with HIV and human
tissue or chimeric human/mouse tissue [Bonyhadi et al.,
1995; Greiner et al., 1996; Choudhary et al., 2005].
Other investigators found 50, 100 and 120 kDa CV-B
binding proteins in mouse thymus [Selinka et al., 1998]
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TABLE III. Release of Viral Particles by Murine Foetal Thymus Organ Cultures Infected
with CV-B4 E2 at Different Times Post-Infection
Viral titre in supernatants of CV-B4 E2-infected foetal thymus organ cultures
(TCID50 ml
1)a (mean valueSD, n¼ 4)
Day 0 p.i. Day 3 p.i. Day 7 p.i.
440,7 85,6 4087,1 1307,9* 386,5 501,825
aViral titres in culture supernatants were obtained by using Reed–Muench’s method on Vero cell cultures.
*P<0.01.
Fig. 1. Effects of CV-B4 on thymus integrity. Foetal thymus organ
cultures were infected with mock (a-d) or CV-B4 E2 (e-h) at 104 TCID50
per lobe. At 7 day p.i. haematoxylin-eosin staining of sections
was performed (a-c and e-g). Cellular cytokeratins were detected by
indirect immunofluorescence staining white signal (d,h). Representa-
tive sections passing through the cortex are shown at three different
magnifications: 100_ (a,e), 200_ (b,d,f,h) and 400_ (c,g).
Fig. 2. Effects of CV-B4 infection on thymocyte differentiation.
Murine foetal thymus organ cultures were infected with CV-B4 E2,
then at 7 days post-infection, thymocytes were dissociated and stained
with anti-CD3, anti-CD4 and anti-CD8 antibodies and analysed by
FACS. Histograms represent the DN and DP thymocyte populations
among immature cells (CD3) and the CD4þ and CD8þ thymocyte
populations among mature cells (CD3þ). Results are expressed as mean
percentages standard deviation, n¼ 4. *P< 0.05 versus mock. DN:
double negative CD4CD8; DP: double positive CD4þCD8þ.
Murine Foetal Thymus Organ Cultures Infected With CV-B4 663
and described the in vivo infection of adult mouse
thymus by CV-B4 E2 [Chatterjee et al., 1992],
or detected viral RNA in thymus of mice inocu-
lated with CV-B3 [Klingel et al., 1996] but, to the
best of our knowledge, it is the first time that a
study describes the ex vivo infection of foetal mouse
thymus with a CV-B. Altogether, these data clearly
demonstrate the permissiveness of mouse thymus to
CV-B infections.
The present study demonstrates that CV-B4 E2
replicates in murine foetal thymus organ cultures as
evidenced by the detection of negative-stranded RNA
within CV-B4 E2-infected lobes, and by the release
of infectious particles in culture supernatants. CV-B4
E2 infection was productive, characterised by a 10-fold
increase in supernatant viral titre and a 15- to 20-fold
increase in intracellular CV-B4 RNA copies number
within foetal thymus organ cultures on day 3 compared
with the residual levels on day 0 p.i., followed by
decreased values of viral titre and RNA copies number
on day 7, without total viral clearance. By contrast,
when thymus lobes were infected with the prototype
CV-B4 JVB strain, the levels of infectious particles in
culture supernatants, and the numbers of RNA copies
within infected lobes decreased from day 0 to day 7 p.i.
Thus it appeared that CV-B4 JVB did not infect thymic
lobes or at a very low level not detected in those
experiments (data not shown).
In the present investigation no significant difference
was observed between intracellular positive- and neg-
ative-strand RNA amounts, except on day 3 when the
level of negative-strand RNA was twice as high as the
one of positive-strand RNA. In other systems, the level
of negative-strand RNA is usually lower than the one
of positive-strand RNA. Indeed, in a previous study of
human foetal thymus infected with CV-B4 E2, the
positive- to negative-strand RNA ratio ranged between 3
and 5 [Brilot et al., 2004]. That ratio ranged between 1
and 3.5 in a murine thymic epithelial cell line, and was
higher in the Hep-2 cell line, as assessed by quantitative
real time RT-PCR (Hober et al., unpublished data). The
production of equal amounts of positive and negative
RNA strands has been observed in persistently infected
myocardial cells [Klingel et al., 1992] in which viral gene
expression is decreased, reflecting restricted viral RNA
synthesis [Kandolf et al., 1999]. It has also been shown
that the infection of myoblasts with CV-B1 resulted in
the formation of stable double-stranded RNA complexes
[Tam and Messner, 1999]. In those studies, the acute
infection was over and persistence of viral RNA occurred
in the absence of infectious virus production. In the
current model in which cultures have been examined for
7 days p.i., with infectious virus production on day 3 p.i.,
one possible explanation for the balanced levels of
intracellular negative and positive RNA strands, is the
relatively low level of CV-B4 E2 replication in murine
foetal thymus organ cultures, in so far as the levels of
intracellular viral RNA per ng of total RNA is 103- to 105-
fold lower than the ones obtained in human Hep-2 cells
infected with CV-B4 E2 (Hober et al., unpublished data).
In the current investigation, CV-B4 E2 infection did
not damage the architecture of foetal thymic tissue and
did not induce any obvious cell lysis, which is reminis-
cent of previously described in vitro studies of CV-B
infections without cytopathic effect in human thymic
epithelial cells [Brilot et al., 2002], pancreatic b-cells
[Yoon et al., 1978; Chehadeh et al., 2000a], lymphoid cell
lines [Matteucci et al., 1985], glomerular and tubular
cells, or vascular endothelial cells [Conaldi et al.,
1997a,b]. Altogether these data show that CV-B can
infect various tissues without dramatic cell lysis in
contrast with the effect of those viruses in continuous
epithelial cell lines such as Hep-2, Vero and KB. In a
previous investigation performed with human foetal
thymus, cytopathic effect of CV-B4 E2 was observed
with lower virus doses (6- to 60-fold), whereas viral
replication was higher compared with that in murine
foetal thymus organ cultures, since the levels of intra-
cellular viral RNA were in continual increase until day 7
p.i. reaching 55 103 copies of positive-stranded RNA
per ng of total RNA [Brilot et al., 2004].
The difference of results obtained between the murine
foetal thymus organ cultures and the human foetal
thymus systems can be due to the fact that mouse foetal
thymic lobes were not disrupted and used as a whole,
whereas human foetal thymi were dissected into small
pieces, which can make cells more accessible to the
virus, in so far as it has been reported that dispersing
cells from tissues increases virus infectivity [Rotbart
and Kirkegaard, 1992]. An alternative explanation is
that murine foetal thymic cells are more resistant to CV-
B4 E2 infection than human foetal thymic cells, given
that this virus is a human pathogen which has not been
adapted previously to murine cells in the current
experiments. These differences explain why CV-B4 E2
infection of murine foetal thymus organ cultures did not
result in severe thymocyte depletion such as that
observed in the previous investigation on human foetal
thymus [Brilot et al., 2004].
In contrast with the silent effect of CV-B4 E2 infection
on survival and on tissue integrity in the murine foetal
thymus organ cultures system, a disturbance of thymo-
cyte differentiation was noticed. Maturation and differ-
entiation of T cells were different between CV-B4 E2-
infected and mock-infected foetal thymus organ cul-
tures. Increased percentages of mature CD4þ cells and
CD8þ cells were observed and the percentage of DN cells
increased, whereas the percentage of immature DP cells
decreased. These data suggest that CV-B4 E2 infection
of the murine foetal thymus may exert an impact on two
checkpoints of T-cell differentiation: first on early
differentiation from DN to DP T cells, and secondly on
positive selection of single positive SP CD4þ and CD8þ
from DP T cells. Changes in the maturation of
lymphocytes in foetal thymus organ cultures infected
with the prototype CV-B4 JVB strain have been studied.
There was no significant effect with that virus, which is
in agreement with the absence (or very low level) of
infection with that non-diabetogenic strain (data not
shown).
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In the present model of murine foetal thymus organ
cultures, thymocyte profiles were unchanged in cultures
infected with UV-irradiated or antibody-neutralized
CV-B4 E2 compared to mock-infected cultures (data
not shown), demonstrating that that effect on thymocyte
differentiation was directly and specifically associated
with virus replication.
The marked increase in the percentage of DN cells in
CV-B4-infected foetal thymus organ cultures obtained
in the current study is in agreement with a 150%
increase in thymic DN cells observed by Chatterjee et al.
[1992] in CV-B4 E2-infected adult mice which preceded
the onset of hyperglycaemia in those animals. Alto-
gether these data raise the question of the role of thymus
disorders resulting from viral infections in the patho-
genesis of type 1 diabetes. The role of alterations in
T lymphocyte subsets in the development of the disease
cannot be excluded in so far as they have been observed
in NOD mice, BB rats and diabetic patients [Jackson
et al., 1981; Poussier et al., 1982; Johnston et al., 1988;
Faustman et al., 1991; Zipris et al., 1991]. Whether CV-
B4-induced disturbances of thymic cells during foetal
life can play a role in type 1 diabetes pathogenesis, by
impairing T-cell differentiation, central self-tolerance
and homeostasis, should be investigated further.
Since a vertical transmission of CV-B has been
reported in mice models [Drouhet and Leventis, 1968;
Modlin and Crumpacker, 1982; Pavlenko et al., 1992;
Abzug et al., 1997], further work should be performed in
order to determine whether murine foetal thymus can be
infected in vivo, and whether the infection of that organ
in utero can play a role in the development of auto-
immune diseases such as type 1 diabetes.
The mechanism by which CV-B4 infection disturbs
the thymocyte subpopulations in the murine foetal
thymus organ cultures is still unclear. Based on the
results of the current study, further investigations
should be performed ex vivo to study the infection of
murine foetal thymus with viruses like CV-B4 E2, and
its consequences onto thymic functions. The murine
foetal thymus organ cultures system opens up the
possibility to determine factors that can affect T-cell
differentiation, especially viruses.
In conclusion, the present study shows that the ex vivo
infection of foetal thymus organ cultures from CD-1 mice
with CV-B4 E2 has an impact on T-cell differentiation in
that system.
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